Multiple microbial species – broad, non-specific

The term Multiple microbial species – broad, non-specific refers to a pharmacological classification for agents that exhibit bioactivity against a diverse range of pathogens, including various bacteria, fungi, or viruses (ChEMBL Database, 2024). This designation is typically applied when a drug does not target a single, specific protein but instead affects fundamental biological processes common to many microorganisms or acts through non-specific chemical mechanisms (DrugBank Online, 2024). Examples include broad-spectrum antibiotics like tetracyclines, which inhibit protein synthesis across many bacterial species, and antiseptics like ethanol, which cause non-specific protein denaturation (StatPearls, Antiseptics and Disinfectants, 2023). While these agents are vital for treating infections of unknown etiology, their lack of specificity can lead to significant clinical challenges, most notably the emergence of antimicrobial resistance and the disruption of the host's normal microbiome (NIH, Antimicrobial Resistance, 2022). In drug discovery and bioinformatics, this category serves as a placeholder for drugs whose therapeutic effects are organism-wide or multi-species in nature rather than being mediated by a discrete human or microbial receptor.

Other names

Broad-spectrum antimicrobial targetNon-specific microbial pathogensMulti-species microbial activityGeneral microbial target

Inhibition of highly conserved microbial pathways such as cell wall synthesis, protein translation, or DNA replication across diverse species, or non-specific physical disruption of microbial membranes and protein structures (PubMed, PMID: 30256564; StatPearls, 2023).